Download PDF
Am J Perinatol 1997; 14(1): 5-6
DOI: 10.1055/s-2007-994087
ORIGINAL ARTICLE

© 1997 by Thieme Medical Publishers, Inc.

Is Maternal Thyrotropin Releasing Hormone Administration Safe in the Pregnant Woman with Preeclampsia?

Ann S.A. Tan, Chaur-Dong Hsu, Sara Marder, Joshua A. Copel
  • Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Yale-New Haven Hospital, Yale University School of Medicine, New Haven, Connecticut
Further Information

Publication History

Publication Date:
04 March 2008 (online)

Also available at
    Permissions and Reprints

ABSTRACT

Maternal intravenous administration of thyrotropin releasing hormone (TRH) is associated with rapid elevations of blood pressure, potentially causative of cerebrovascular accidents. We report a case in which peak blood pressure of 220/120 mm Hg was attained from a baseline of 132/80 mm Hg following TRH administration in a preeclamptic patient.

Keywords

Preeclampsia - thyrotropin releasing hormone (TRH) - blood pressure